ProfileGDS5678 / 1416878_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 19% 21% 21% 21% 15% 19% 24% 21% 35% 22% 21% 21% 23% 26% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4876619
GSM967853U87-EV human glioblastoma xenograft - Control 22.4910721
GSM967854U87-EV human glioblastoma xenograft - Control 32.497321
GSM967855U87-EV human glioblastoma xenograft - Control 42.452621
GSM967856U87-EV human glioblastoma xenograft - Control 52.3239915
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5274419
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.5856224
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4735221
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.7738535
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.5043622
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.480921
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4704121
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.5337223
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.6027526